Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
Showing 1,521 - 1,540 results of 13,437 for search '(( significantly increased decrease ) OR ( significant ((shape decrease) OR (greater decrease)) ))', query time: 0.57s Refine Results
  1. 1521
    The study timeline.

    The study timeline. by Monireh Mahmoudi (21989413)

    Published 2025
    “…This illusion of ongoing freshness could decrease the frequency of quality checks and delay initial inspections, ultimately increasing the risk of spoilage and waste. …”
    Save to List
    Saved in:
  2. 1522
    Effects of finerenone on the UACR in all patients.

    Effects of finerenone on the UACR in all patients. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1523
    Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time.

    Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1524
    Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients.

    Changes in blood pressure, HbA1c, blood lipids and liver function-related indicator values from 3 months to 6 months of treatment in all patients. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1525
    Changes in the UACR and urinary β2-MG levels compared with baseline values over time.

    Changes in the UACR and urinary β2-MG levels compared with baseline values over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1526
    Changes in the eGFRs and serum potassium levels compared with baseline values in all patients over time.

    Changes in the eGFRs and serum potassium levels compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1527
    Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups.

    Comparison of the rates of decline in the UACR and urinary β2-MG levels between the two subgroups. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1528
    Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time.

    Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1529
    Changes in inflammatory cytokine levels compared with baseline values in all patients over time.

    Changes in inflammatory cytokine levels compared with baseline values in all patients over time. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1530
    Effects of finerenone on the urinary β2-MG levels in all patients.

    Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1531
    S1 Data -

    S1 Data - by Taher Mohammadizad (19786989)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1532
    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B).

    The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1533
    Fig 3 -

    Fig 3 - by Aihong Zheng (20571034)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1534
    Complication subgroup analysis of the RAAS system in T2DM patients.

    Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1535
    Flow diagram of patient selection and subgroup classification.

    Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1536
    Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients.

    Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1537
    The values of angiotensin II

    The values of angiotensin II by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1538
    Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC.

    Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC. by Aihong Zheng (20571034)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1539
    S1 Fig -

    S1 Fig - by Aihong Zheng (20571034)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1540
    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups.

    Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: